Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2012
11/08/2012US20120283296 Pyrrolopyrazoles for treating cns disorders
11/08/2012US20120283295 Indazole derivatives and their use for blockading voltage dependent sodium channels
11/08/2012US20120283293 Methods of neuroprotection involving Prostaglandin E2 EP4 (PGE2 EP4) receptor activation
11/08/2012US20120283283 Methods for detecting enhanced risk of opioid-induced hypoxia in a patient
11/08/2012US20120283275 Methods and dosage forms for reducing side effects of benzisozazole derivatives
11/08/2012US20120283274 Crystalline forms of substituted pyrazolopyrimidines
11/08/2012US20120283273 Indole and azaindole modulators of the alpha 7 nachr
11/08/2012US20120283270 Extracts and beverages containing 2,5-piperazinedione,3,6-bis(phenylmethyl)-, (3s,6s)-
11/08/2012US20120283269 Method and Compositions for Suppression of Aging
11/08/2012US20120283268 Thiazole and Thiophene Analogues, and Their Use in Treating Autoimmune Diseases and Cancers
11/08/2012US20120283264 Oxazolidinones as Modulators of MGLUR5
11/08/2012US20120283262 Pharmaceutical compositions comprising sigma receptor ligands
11/08/2012US20120283259 Novel inhibitors
11/08/2012US20120283256 New heterocycle compounds and uses thereof for the prevention or treatment of diseases involving formation of amyloid plaques and/or where a dysfunction of the app metabolism occurs
11/08/2012US20120283255 Urea derivatives, methods for their manufacture, and uses therefor
11/08/2012US20120283254 Novel benzofurane-piperidine compounds
11/08/2012US20120283248 Composition and method for treating cognitive impairments in down syndrom subjects
11/08/2012US20120283247 Diazepane acetamide derivatives as selective 11b-hsd1 inhibitors
11/08/2012US20120283246 Novel parenteral carbamazepine formulation
11/08/2012US20120283245 Azabicyclo[3.1.0]hex-2-yl compounds, a process for their preparation and pharmaceutical compositions containing them
11/08/2012US20120283244 Association between 4-benzamide and an acetylcholinesterase inhibitor, and pharmaceutical compositions containing it
11/08/2012US20120283243 Spiroindoline Modulators of Muscarinic Receptors
11/08/2012US20120283239 1H-[1,2,3]TRIAZOLO[4,5-c]PYRIDINE-4-CARBONITRILE DERIVATIVES
11/08/2012US20120283238 Irak inhibitors and uses thereof
11/08/2012US20120283236 Porphyrin Catalysts and Methods of Use Thereof
11/08/2012US20120283229 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
11/08/2012US20120283223 Cerebral nerve cell neogenesis agent
11/08/2012US20120283217 Modulators of amyloid-beta production
11/08/2012US20120283212 Use of polysaccharides for treating stress and anxiety
11/08/2012US20120283199 Neuroprotective ganglioside compositions for use in treating or diagnosing huntington's disease
11/08/2012US20120283193 Manipulation of brain in a circuit-specific manner
11/08/2012US20120283187 Controlled release composition and method of producing the same
11/08/2012US20120283181 Crystal forms of saxagliptin and processes for preparing same
11/08/2012US20120283178 Learning motivation improvers
11/08/2012US20120283170 Acylated Exendin-4 Compounds
11/08/2012US20120283169 Pharmaceutical composition, methods for treating and uses thereof
11/08/2012US20120283168 Template-fixed peptidomimetics with ccr10 antagonistic activity
11/08/2012US20120282353 Methods, compositions and articles of manufacture for hif modulating compounds
11/08/2012US20120282350 Performance enhancing compositions and methods of use
11/08/2012US20120282338 Extended Release Formulation
11/08/2012US20120282337 Modified Release Formulation
11/08/2012US20120282336 Bilayer tablet formulations
11/08/2012US20120282322 Cochleate compositions directed against expression of proteins
11/08/2012US20120282307 Gastric retained gabapentin dosage form
11/08/2012US20120282303 Percutaneous absorption preparation comprising anti-dementia drug
11/08/2012US20120282298 Corticosteroids for the treatment of joint pain
11/08/2012US20120282275 Methods and compositions for regulation of neurological conditions
11/08/2012US20120282267 Cathepsin inhibitors for the treatment of bone cancer and bone cancer pain
11/08/2012US20120282255 Methods and compositions for the treatment of alcoholism and alcohol dependence
11/08/2012US20120282254 Cd127 binding proteins
11/08/2012US20120282252 5Imidazoquinolines and Pyrimidine Derivatives as Potent Modulators of VEGF-Driven Angiogenic Processes
11/08/2012US20120282248 Prevention and treatment of cerebral amyloid angiopathy
11/08/2012US20120282241 Method of Treating Persistent Genital Arousal Disorder with a Neurotoxin
11/08/2012US20120282227 Methods and compositions for the induction of hypothermia
11/08/2012US20120282223 Amorphous (5-Fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-Acetic Acid
11/08/2012US20120282222 Estrogen receptor ligand and/or interferon beta treatment for neurodegenerative diseases
11/08/2012US20120282191 Orally dispersible tablet
11/08/2012US20120282176 Method and Constructs for the pH Dependent Passage of the Blood-brain-barrier
11/08/2012US20120282170 Anti- tnf antibodies, compositions, methods and uses
11/08/2012CA2835018A1 Pentylenetetrazole derivatives
11/08/2012CA2832302A1 Novel benzofurane-piperidine compounds
11/07/2012EP2520670A1 New polymorphisms in ABCB1 associated with a lack of clinical response to medicaments
11/07/2012EP2520588A1 Dual variable domain immunoglobulin and uses thereof
11/07/2012EP2520577A1 Pyrazolo[1,5-a]pyrimidine compounds as CB1 receptor antagonists
11/07/2012EP2520566A1 New Pharmaceutical Compounds
11/07/2012EP2520308A1 Composition for improving brain function and method for improving brain function
11/07/2012EP2520296A1 New association between 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide and an acetylcholinesterase inhibitor, and pharmaceutical compositions containing it.
11/07/2012EP2520292A1 Use of spirangiens for the treatment or prevention of IL-8 or IL-6 mediated disorders
11/07/2012EP2520290A1 Propofol analogs, process for their preparation, and methods of use
11/07/2012EP2520289A1 Norethisterone-containing patch
11/07/2012EP2520183A1 Use of agents containing Hydroxystilbene for preventing and/or treating illnesses
11/07/2012EP2519633A2 Treatment of nuclear respiratory factor 1 (nrf1) related diseases by inhibition of natural antisense transcript to nrf1
11/07/2012EP2519521A1 Tetrahydrotriazolopyridine compounds as selective mglu5 receptor potentiators useful for the treatment of schizophrenia
11/07/2012EP2519515A1 Pyrazine derivatives and their use in the treatment of neurological disorders
11/07/2012EP2519514A2 Alpha4beta2 neuronal nicotinic acetylcholine receptor ligands
11/07/2012EP2519511A1 Novel piperine derivatives as gaba - a receptors modulators
11/07/2012EP2519242A1 Sulphated disaccharides for the treatment of neurodegenerative and/or neurovascular diseases
11/07/2012EP2519241A2 Methods for treating autism
11/07/2012EP2519238A1 Beta-carbolines for use in the treatment of hearing loss and vertigo
11/07/2012EP2519234A1 Anaplerotic therapy for alzheimer's disease and the aging brain
11/07/2012EP2519233A1 Pharmaceutical composition for treating alcohol dependency
11/07/2012EP2519227A2 Management of myoclonus with oral liposomal reduced glutathione
11/07/2012EP2519101A1 Amino acid conjugates of quetiapine, process for making and using the same
11/07/2012DE20321906U1 Pramipexol-Dosierform zur einmal täglichen Verabreichung Pramipexole dosage for once daily administration
11/07/2012CN1943585B Breviscapine proliposome powder preparation
11/07/2012CN1871240B Pyrrolopyrimidine thion derivatives
11/07/2012CN102770435A Pyrazolopyrimidine compounds and their use as PDE10 inhibitors
11/07/2012CN102770150A Composition for promoting the activity of peroxisome proliferator-activated receptor-delta
11/07/2012CN102770142A Diazoxide for use in the treatment of a central nervous system (CNS) autoimmune demyelinating disease
11/07/2012CN102770138A Nicotine-containing soft gelatin pastilles
11/07/2012CN102770124A Formulation comprising 1 H - quinazoline - 2, 4 - dione ampa receptor antagonists, in the form of immediate release tablets and preparation thereof
11/07/2012CN102770120A Compositions and methods for mild sedation, anxiolysis and analgesia in the procedural setting
11/07/2012CN102766214A Protein tag-containing SUMO fusion protein and application thereof
11/07/2012CN102766210A Human CTLA-4 antibodies and their uses
11/07/2012CN102766186A Preparation method and application of ecdysone-rich plant standardized extract
11/07/2012CN102766165A Methods for synthesizing molybdopterin precursor z derivatives
11/07/2012CN102766145A Fluorinated aza imidazolone derivative, synthesis method and application thereof
11/07/2012CN102766080A Pyrrolidine derivative, its preparation method and application thereof
11/07/2012CN102766079A Pyrrolidine derivative, its preparation method and application thereof
11/07/2012CN102764439A Association between 4-benzamide and an acetylcholinesterase inhibitor, and pharmaceutical compositions containing it
1 ... 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 ... 1833